NAYA NASDAQ
NAYA Biosciences, Inc.
1W: -9.2%
1M: -7.3%
3M: -61.0%
1Y: -84.0%
3Y: -99.5%
$2.20
Last traded 2025-05-22 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
9 relationships0
As Filer
counterparties named
9
As Counterparty
mentioned by others
2023-10-26
Earliest Filing
2024-12-12
Latest Filing
Mentioned As Counterparty
9 mentionsOther companies that named NAYA in their SEC 8-K filings.
| Filed By | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|
| IVF NAYA Biosciences, Inc. | target | Former name of LEGACY INVO, parent company of INVO Merger Sub. Inc. | 2024-12-12 | View |
| IVF INVO Bioscience, Inc. | partner | Original party to the Securities Purchase Agreement joining INVO | 2024-10-15 | View |
| IVF INVO Bioscience, Inc. | partner | Counterparty in proposed merger referenced as condition for early repayment right. | 2024-07-05 | View |
| IVF INVO Bioscience, Inc. | investor | Subscriber purchasing Series A Preferred Stock | 2024-05-06 | View |
| IVF INVO Bioscience, Inc. | target | Agreed to purchase 1,000,000 shares of Series A Preferred Stock and is the target of the merger. | 2024-01-10 | View |
| IVF INVO Bioscience, Inc. | investor | Purchased 1,000,000 shares of Series A Preferred Stock in a securities purchase agreement. | 2024-01-10 | View |
| IVF INVO Bioscience, Inc. | investor | Subscriber purchasing Series A Preferred Stock | 2024-01-03 | View |
| IVF INVO Bioscience, Inc. | acquirer | Wholly-owned subsidiary whose shares were the subject of the exchange agreement. | 2023-11-20 | View |
| IVF INVO Bioscience, Inc. | acquirer | Target company being acquired by INVO Bioscience, Inc. | 2023-10-26 | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR